848357-29-9 Usage
Molecular weight
284.32 g/mol
Structure
A indole ring system with a carboxylic acid group (COOH) attached to the 1-position, an acetyl group (CH3CO) bonded to the 5-position, and a boron atom (B) bonded to the 2-position with a t-butyl group (C(CH3)3) attached as an ester.
Derivative of indole-1-carboxylic acid
The compound is derived from the core structure of indole-1-carboxylic acid by introducing functional groups.
Ester form
The compound is an ester, with the t-butyl group attached to the carboxylic acid group.
Borono moiety
A boron atom (B) bonded to a carbon and oxygen atom, which can be used as a source of boron in organic synthesis.
Acetyl group
A functional group containing a carbonyl group (C=O) bonded to a methyl group (CH3), which can be used as a protecting group or a handle for further functionalization.
Potential applications
The compound has potential applications in organic synthesis and pharmaceutical research, as boron-containing compounds have been studied for their potential as enzyme inhibitors and pharmaceutical agents.
Stability
The t-butyl ester group imparts stability to the compound, making it useful for storage and handling in laboratory settings.
Check Digit Verification of cas no
The CAS Registry Mumber 848357-29-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,3,5 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 848357-29:
(8*8)+(7*4)+(6*8)+(5*3)+(4*5)+(3*7)+(2*2)+(1*9)=209
209 % 10 = 9
So 848357-29-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H18BNO5/c1-9(18)10-5-6-12-11(7-10)8-13(16(20)21)17(12)14(19)22-15(2,3)4/h5-8,20-21H,1-4H3
848357-29-9Relevant academic research and scientific papers
THIENOPYRAZOLES
-
Page/Page column 73-74, (2008/06/13)
Thienopyrazoles, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical uses in the treatment of disease states capable of being modulated by the inhibition of the protein kinases, in particular interleukin-2 inducible tyrosine kinase (ITK).
